Medical Advisory - Heightened Surveillance for Pertussis Infections

Released August 16, 2017

Issued by: M. Mustafa Hirji, MD, MPH, FRCPC Associate Medical Officer of Health

Background

  • Niagara Region Public Health has received 14 laboratory confirmed cases of pertussis between June and July 2017
  • In June and July last year, NRPH received less than five confirmed cases of pertussis
  • All health care providers are encouraged to be on heightened surveillance for pertussis

Clinical Presentation

  • ​Cough lasting 2 weeks or longer
  • Paroxysmal cough of any duration
  • Cough with inspiratory “whoop”
  • Cough ending in vomiting, or associated with apnea

Managing Suspect Cases

  • Advise patient not to attend childcare, school, work, or public places; patients are no longer contagious after 5 days of appropriate treatment
  • Advise to avoid contact with infants ≤ 1 year of age, pregnant women and immunocompromised individuals

** Please report immediately to NRPH **

Testing

Immunization Considerations

  • ​Ensure immunizations are up to date
  • The current schedule for acellular pertussis vaccine is 2, 4, 6, and 18 months, 4-6 years, and 14-16 years
  • Adults should receive at least dose sometime after the age of 18 years
  • It takes approximately 2 weeks to develop immunity after immunization

For further information, please contact Niagara Region Public Health, Infectious Disease program at 1-888-505-6074 or 905-688-8248 ext. 7330 (Mon. - Fri., 8:30 a.m. to 4:30 p.m.) or after hours at 905-984-3690​


Page Feedback Did you find what you were looking for today?